Preliminary results raise hope for darunavir in HIV-1BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7598.823-a (Published 19 April 2007) Cite this as: BMJ 2007;334:823
Two phase IIB trials assessed the effectiveness of adding darunavir, a new protease inhibitor, to low dose ritonavir for treating people with HIV-1 who had a history of previous treatment. Participants were being treated with regimens containing protease inhibitors at baseline, and they had a history …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial